BE1000175A3 - Vaccins contre le melanome. - Google Patents

Vaccins contre le melanome. Download PDF

Info

Publication number
BE1000175A3
BE1000175A3 BE8700094A BE8700094A BE1000175A3 BE 1000175 A3 BE1000175 A3 BE 1000175A3 BE 8700094 A BE8700094 A BE 8700094A BE 8700094 A BE8700094 A BE 8700094A BE 1000175 A3 BE1000175 A3 BE 1000175A3
Authority
BE
Belgium
Prior art keywords
sep
virus
protein
peptide
recombinant
Prior art date
Application number
BE8700094A
Other languages
English (en)
French (fr)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE1000175(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Application granted granted Critical
Publication of BE1000175A3 publication Critical patent/BE1000175A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE8700094A 1986-02-07 1987-02-06 Vaccins contre le melanome. BE1000175A3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (1)

Publication Number Publication Date
BE1000175A3 true BE1000175A3 (fr) 1988-07-12

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700094A BE1000175A3 (fr) 1986-02-07 1987-02-06 Vaccins contre le melanome.

Country Status (18)

Country Link
JP (3) JP2664673B2 (es)
BE (1) BE1000175A3 (es)
CH (1) CH675424A5 (es)
DE (1) DE3703702C2 (es)
DK (1) DK63287A (es)
ES (2) ES2012815A6 (es)
FI (1) FI94836C (es)
GR (1) GR870195B (es)
HU (1) HU209144B (es)
IE (1) IE59597B1 (es)
IT (1) IT1222359B (es)
MX (1) MX9203574A (es)
NL (1) NL8700285A (es)
NO (1) NO178931C (es)
NZ (1) NZ219192A (es)
OA (1) OA08478A (es)
PT (1) PT84255B (es)
SE (2) SE506024C2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
NATURE, vol. 296, 11 mars 1982, pages 171-173; M.P. BROWN et al.: "Human melanoma-associated antigen p97 is structurally and functionally related to transferrin" *
NATURE, vol. 315, 13 juin 1985, pages 592-595; S. MAEDA et al.: "Production of human alpha-interferon in silkworm usig a baculovirus vector" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCEINCES OF THE USA, vol. 80, mars 1983, pages 1194-1198, Washington, US; R.A. YOUNG et al.: "Efficient isolation of genes by using antibody probes" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 82, no. 1, janvier 1985, pages 19-23, Washington, US; M.A. COCHRAN et al.: "Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 82, no. 5, mars 1985, pages 1359-1363, Washington, US; S.L. MANSOUR et al.: "An adenovirus vector system used to express polyoma virus tumor antigens" *
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 83, mars 1986, pages 1261-1265, Washington, US; T.M. ROSE et al.: "Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence" *
PROGRESS IN CANCER RESEARCH AND THERAPY, vol. 32, 1985, pages 157-167, Raven Press, New York, US; J.P. BROWN et al.: "Isolation of cDNA clone for human melanoma-associated antigen p97" *

Also Published As

Publication number Publication date
DK63287A (da) 1987-08-08
FI94836B (fi) 1995-07-31
IE59597B1 (en) 1994-03-09
SE8700466D0 (sv) 1987-02-06
FI870501L (fi) 1987-08-08
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
ES2017258A6 (es) 1991-01-16
NZ219192A (en) 1991-10-25
JPH08280390A (ja) 1996-10-29
NL8700285A (nl) 1987-09-01
DE3703702A1 (de) 1988-02-18
OA08478A (fr) 1988-07-29
CH675424A5 (en) 1990-09-28
FI94836C (fi) 1995-11-10
IT1222359B (it) 1990-09-05
FI870501A0 (fi) 1987-02-06
JPS62294698A (ja) 1987-12-22
JP2664673B2 (ja) 1997-10-15
JPH09135692A (ja) 1997-05-27
SE8700466L (sv) 1987-08-08
MX9203574A (es) 1992-07-01
GR870195B (en) 1987-06-10
HUT43107A (en) 1987-09-28
DE3703702C2 (de) 1997-07-10
NO870475D0 (no) 1987-02-06
DK63287D0 (da) 1987-02-06
SE9202934D0 (sv) 1992-10-07
PT84255A (en) 1987-03-01
IT8719291A0 (it) 1987-02-06
ES2012815A6 (es) 1990-04-16
NO178931C (no) 1996-07-03
NO178931B (no) 1996-03-25
NO870475L (no) 1987-08-10
IE870319L (en) 1987-08-07
HU209144B (en) 1994-03-28

Similar Documents

Publication Publication Date Title
LU86765A1 (fr) Vaccins contre le melanome
US5141742A (en) Vaccines against melanoma
DE69725428T2 (de) Menschliches krebsagent des tyrosinase ähnlichen proteins 1 und gene, die es kodieren
JPH08505878A (ja) 免疫原のリソソーム標的
MC2039A1 (fr) Proteine ayant un ou plusieurs determinants immuno-reactifs et/ou antigeniques d'un antigene de surface d'eimeria,utilisation et procede de preparation
EP0259212A1 (fr) Expression d'un antigène spécifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement préventif ou curatif de la tumeur correspondante
JP2757987B2 (ja) ヒト抗‐炎症ホスホリパーゼ阻害蛋白
JP2001505407A (ja) 腫瘍壊死因子関連リガンド
JPH08502244A (ja) 免疫調節ペプチド
PT2358745T (pt) Leucolectinas e suas utilizações
GB2188637A (en) Vaccines against melanoma
JPH08505772A (ja) 新たな寄生蠕虫蛋白質
EP0268501B1 (fr) Protéines à activité glutathion-S-transférase, séquences d'ADN, anticorps, poxvirus et médicaments pour la prévention de la schistosomose
MC2227A1 (fr) Procede pour preparer une proteine ayant un ou plusieurs determinants immunoreactifs et/ou antigeniques de l'antigene de surface des merozoites d'eimeria,adn codant pour cette proteine,procede de preparation d'un vecteur recombinant comprenant cet adn,procede de preparation d'un microorganisme transforme contenant ce vecteur recombinant et procede pour preparer un vaccin protegeant les volailles contre la coccidiose
BE1000175A3 (fr) Vaccins contre le melanome.
WO2011091716A1 (zh) 表皮生长因子受体变异体
JP2000501925A (ja) 寄生性蠕虫マクロファージ遊送阻害因子タンパク質、核酸分子、およびそれらの用途
US7544485B2 (en) Baldness related gene and the polypeptide encoded thereby, and uses
JP2001017188A (ja) 新規なｖｅｇｆ／ｐｄｇｆ様因子
US5785986A (en) Water channel
JP2001502161A (ja) 寄生蠕虫毒アレルゲン抗原５様遺伝子およびタンパク質
CN115710307A (zh) 蝎毒素及其突变体在抗癫痫中的应用
US20080096833A1 (en) Polytpeptide Specific To Liver Cancer, Polynucleotide Coding For The Polypeptide, And Rna Molecule Inhibiting Expression Of The Polypeptide
WO2004022589A1 (fr) Marqueur tumoral et ses applications
JP2004041084A (ja) ヘリコバクター・ピロリ菌に対するワクチン用ペプチド、それをコードする遺伝子、その遺伝子が導入された形質転換体、及びそれらの利用方法

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ONCOGEN

Effective date: 19990228